Navigation Links
CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
Date:1/18/2010

PLEASANTON, Calif., Jan. 18 /PRNewswire/ -- CooperVision today announced that Richard Clompus, OD, FAAO, has joined the company as vice president, global professional relations within the Global Commercial Strategy team. Dr. Clompus will support clinical studies, education, and professional affairs on a worldwide basis in order to further establish CooperVision's position in the global contact lens industry.

"Richard brings a wealth of experience and technical expertise to this role," said Jeffrey A. McLean, executive vice president, Global Commercial Strategy, CooperVision. "We look forward to his contribution as we continue to develop our professional relations strategy, clinical programs, and enhance the overall experience of our customers."

Dr. Clompus most recently served as director of The Vision Care Institute, LLC, supporting student and doctor education in the U.S., Canada, and Puerto Rico. Prior to that, he was part of Johnson & Johnson Vision Care where he held leadership positions within The Spectacle Lens Group and Vistakon. He is a member of the American Optometric Association, charter member of the AOA Contact Lens Section, and Fellow of the American Academy of Optometry.

Dr. Clompus was also in private practice for 20 years, establishing an innovative optometric practice in West Chester, Pa., providing multidisciplinary eye care and contact lens specialty services. He has exceptional expertise in the use of multimedia technologies for presentations and training, published many journal articles, and is a contributing author to several publications. Dr. Clompus graduated from the Pennsylvania College of Optometry and completed a family practice residency at the University of Alabama School of Optometry in Birmingham. 

He and his family will be relocating to CooperVision's global headquarters in Pleasanton, Calif.  

About CooperVision

CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world's leading manufacturers of soft contact lenses. Dedicated to enhancing the contact lens experience for practitioners and patients, CooperVision specializes in lenses for astigmatism, presbyopia, and ocular dryness. CooperVision manufactures a full array of monthly, two-week, and daily disposable contact lenses featuring advanced materials and optics. For more information, visit www.coopervision.com.

SOURCE CooperVision

RELATED LINKS
http://www.coopervision.com

'/>"/>

SOURCE CooperVision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Putney to Present at the Jefferies 2010 Global Healthcare Services Conference
2. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
3. WellTek Subsidiary MedX Limited Increases Presence in Global Market
4. Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
5. Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities
6. Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective
7. Reportlinker Adds Radiation Therapy Equipment - A Global Market Review
8. Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities
9. Reportlinker Adds Training Manikins - Global Trends
10. Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly
11. Global Announces Contract To Acquire New Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 2016 Research and Markets has announced ... report to their offering. ... The report forecasts the global optical transceiver market to ... The report covers the present scenario and the growth ... the market size, the report considers the revenue generated from the ...
(Date:12/9/2016)... Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged ... rare diseases, today announced that senior management will participate in a ... at the InterContinental Barclay Hotel in New York City ... About aTyr Pharma ... aTyr Pharma is engaged in the discovery ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
Breaking Medicine Technology:
(Date:12/9/2016)... Harrisburg, PA (PRWEB) , ... December 09, 2016 ... ... concussion education program through the Pennsylvania Cable Network (PCN) during the summer of ... Brain Injury Implementation Grant provided by the United States Department of Health and ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... CURE Media Group, ... and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung ... announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
Breaking Medicine News(10 mins):